Gaurav Singh
MOHS-Micrographic Surgery · Milwaukee, WINPI 1184073801
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,368 of the $78,570 with a category attached, or 74.3%. Regeneron Healthcare Solutions, Inc. accounts for 78.6% of it on its own, with 21 other manufacturers making up the rest.
Across 183 payments — averaging $429.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$62K
- Sun Pharmaceutical Industries Inc.$14K
- Teladoc Health, Inc.$450
- Johnson & Johnson$373
- VYNE Pharmaceuticals Inc.$332
- Lilly USA, LLC$196
- plus $1K from 16 others
What the payments were for
- Consulting fees$8,96011%
- Speaking & faculty fees$58,36874%
- Travel & lodging$7,64310%
- Food & beverage$3,3804%
- Education$2190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 75 | $61,718 |
| Sun Pharmaceutical Industries Inc. | 28 | $14,387 |
| Teladoc Health, Inc. | 2 | $450 |
| Johnson & Johnson | 11 | $373 |
| VYNE Pharmaceuticals Inc. | 5 | $332 |
| Lilly USA, LLC | 10 | $196 |
| Sanofi | 9 | $190 |
| AbbVie | 10 | $174 |
| Amgen | 6 | $133 |
| UCB, Inc. | 4 | $104 |
| Novartis | 5 | $100 |
| Incyte Corporation | 4 | $77 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Galderma Laboratories, L.p. | 3 | $50 |
| Boehringer Ingelheim | 3 | $50 |
| Regeneron | 1 | $44 |
| Pfizer | 1 | $24 |
| Mimedx Group, Inc. | 1 | $23 |
| Medtronic | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Wisconsinto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 1,272 | $10,005 |
| Doxycycline Hyclate | 393 | $2,693 |
| Cephalexin | 218 | $901 |
| Mupirocin | 19 | $122 |
| Triamcinolone Acetonide | 13 | $112 |
| Clindamycin Hcl | 15 | $26 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Milwaukee
- Zachary KwapnoskiMadison$2K
- Tyler BaumanOak Creek$1K
- Peter LeeEau Claire$1K
- David Bertlerde Pere$382
- Carmen BaldingGlendale$174
- Kevan LewisGreen Bay$143
- Michael ColganEau Claire$100
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.